Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$300,614
-$72,765 QoQ
Shares Held
12,484
-6.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,129
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DAVIS R M INC holds $148,422,330 across 9 Drug Manufacturers - General names. PFE ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
61,458 | $73,714,575 | |
| 2 | JNJ |
Johnson & Johnson
|
249,911 | $63,469,896 | |
| 3 | ABBV |
AbbVie Inc.
|
18,009 | $4,531,784 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,586 | $3,030,801 | |
| 5 | AMGN |
Amgen Inc
|
6,701 | $2,426,566 | |
| 6 | AZN |
Astrazeneca PLC
|
1,871 | $354,779 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,425 | $312,588 | |
| 8 | PFE |
Pfizer Inc
This page
|
12,484 | $300,614 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $300,614 | 12,484 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $373,379 | 13,297 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $293,919 | 11,804 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $328,360 | 12,887 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $328,258 | 13,542 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $590,143 | 23,289 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $645,289 | 24,323 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $1,535,469 | 53,057 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,679,751 | 60,034 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,012,735 | 72,531 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,998,737 | 104,159 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,257,846 | 279,103 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,725,465 | 346,932 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $13,772,325 | 337,557 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $16,552,979 | 323,048 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $13,312,929 | 304,226 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $16,836,478 | 321,123 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $16,608,126 | 320,806 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $18,698,654 | 316,658 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $13,219,897 | 307,368 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $11,738,288 | 299,752 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $9,954,192 | 274,750 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $9,257,715 | 251,500 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $7,756,610 | 211,352 | Shares | Sole | 2020-12-01 | |
| 2020-06-30 | $5,733,754 | 175,344 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $4,711,969 | 144,362 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||